United States - Re-Export of Penicillins or Streptomycins in Dosage Forms
Since 2014, United States Re-Export of Penicillins or Streptomycins in Dosage Forms grew 117.4% year on year. At $21,398,977.04 in 2019, the country was ranked number 2 comparing other countries in Re-Export of Penicillins or Streptomycins in Dosage Forms. Italy lead the ranking with $158,707,704.07 in 2019, that is a decrease of 22% versus 2018. Kenya recorded the best 5 years average growth at +205.7% per year, while Trinidad and Tobago was the worst growing country at -27.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 21,398,977.04 |
| 2018 | 20,672,436.00 |
| 2017 | 20,389,582.00 |
| 2016 | 12,188,918.00 |
| 2015 | 2,150,155.00 |
Download all data from 1991 to 2019
How does United States rank in Re-Export of Penicillins or Streptomycins in Dosage Forms?
| # | 27 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Italy
|
158,707,704.07 | 2019 | -22.0 % | +57.7 % | View data |
| 2 |
#2
United States
|
21,398,977.04 | 2019 | +3.5 % | +117.4 % | View data |
| 3 |
#3
United Arab Emirates
|
10,579,378.12 | 2019 | -15.7 % | +110.9 % | View data |
| 4 |
#4
Saudi Arabia
|
769,489.03 | 2019 | +6.0 % | +23.6 % | View data |
| 5 |
#5
Georgia
|
741,239.31 | 2019 | +663.7 % | +81.9 % | View data |